Key figures

Key figures

2025 2024 2023 2022 2021
in CHF millions1
Net sales 334.1 323.3 361.5 340.9 265.8
Growth rate 3.3% -10.6% 6.1% 28.2% 12.8%
EBITDA 50.3 53.8 65.0 50.2 32.9
EBITDA margin 15.0% 16.6% 18.0% 14.7% 12.4%
Operating result (EBIT) 32.8 39.2 51.9 37.1 21.4
EBIT margin 9.8% 12.1% 14.4% 10.9% 8.1%
Net result 23.4 34.4 45.1 26.0 18.9
Return on equity (ROE) 11.3% 16.2% 20.9% 14.1% 12.9%
Zeochem
Net sales 114.7 117.3 124.2 110.3 95.1
EBITDA 23.9 22.8 22.1 19.1 20.5
EBITDA margin 20.8% 19.5% 17.8% 17.4% 21.5%
Perlen Packaging
Net sales 219.4 206.0 237.3 230.6 170.7
EBITDA 25.9 33.3 42.9 31.4 11.9
EBITDA margin 11.8% 16.1% 18.1% 13.6% 7.0%
Cash flow2 42.5 42.9 54.4 47.1 25.5
Cash flow from operating activities 34.1 53.3 57.9 36.4 21.2
Capital expenditures for fixed assets 21.1 20.4 17.9 26.1 20.4
Free cash flow3 16.4 34.9 54.8 14.6 1.4
Free cash flow margin3 4.9% 10.8% 15.2% 4.3% 0.5%
Total assets 368.9 332.6 327.9 421.0 347.8
Shareholders’ equity 203.9 209.4 216.8 214.2 153.7
Equity ratio 55.3% 63.0% 66.1% 50.9% 44.2%
Net cash 26.2 -12.7 -34.7 -11.5 -41.2
Capital employed 244.1 208.3 192.8 207.0 207.4
Net operating profit after tax (NOPAT) 26.6 32.2 42.8 29.6 18.0
Return on capital employed (ROCE) 11.8% 16.1% 21.4% 14.3% 9.1%
Headcount (FTE) 1244 959 841 809 746
1)  continued divisions; derived from the consolidated financial statements and accounting records 2021 to 2024
2)  before change in non-financial net working capital
3)  before acquisition of subsidiaries

Share information

2025 2024 2023 2022 2021
in CHF
Share price as at 31 December 69.20 73.40 85.00 78.00 61.00
Dividend per share 2.001 2.00 4.00 4.50 1.30
Dividend yield 2.9% 2.7% 4.7% 5.8% 2.1%
Market capitalization (in CHF millions) 415 440 510 468 366
Adjusted (continued divisions)
Share price as at 31 December 69.20 73.40 61.202 56.202 43.902
Earnings per share, remaining divisions2 3.9 5.74 7.50 4.31 3.13
Price-earnings ratio as at 31 December3 17.8 12.8 8.2 13.0 14.0
Dividend per share4 2.001 2.00 2.28 1.15 1.30
Total shareholder return (TSR)5 -3.0% 23.2% 13.0% 30.6% -13.6%
1) Board of Directors’ proposal to the Annual General Meeting of 17 March 2026
2) adjusted for the indicative share of around 28 % of the spun-off Perlen Industrieholding AG
3) continued divisions; derived from the consolidated financial statements and accounting records 2021 to 2024
4) Share from continued divisions based on share of earnings per share
5) continued divisions, see also footnote 2, 3, and 4